Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVEND IT
NCT03073018Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- Apr 1998
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fosinopril, pravastatin in cardiovascular disease (CVD), end stage renal disease (ESRD), sponsored by University Medical Center Groningen. Started Apr 1998; status: completed.
02
Drugs
fosinoprilpravastatin
03
Conditions
cardiovascular disease (CVD)end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03073018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073018.